Home > Financial Ratios > SMS PHARMACEUTICALS

SMS PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
SMS PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SMS PHARMACEUTICALS
Please provide your vote to see the results

SMS PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 23.8919.80103.90-50.38-3.83

What is the latest Core EBITDA Growth ratio of SMS PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of SMS PHARMACEUTICALS is 23.89 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar202623.89
Mar202519.80
Mar2024103.90
Mar2023-50.38
Mar2022-3.83

How is Core EBITDA Growth of SMS PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2026 23.89
20.66
Mar2025 19.8
-80.94
Mar2024 103.9
Positive
Mar2023 -50.38
Negative
Mar2022 -3.83 -

Other Financial Ratios of SMS PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of SMS PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SMS PHARMACEUTICALS ₹3,971.9 Cr -5.2% -8.7% 66% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹419,620.0 Cr -0.2% -5.1% 8.4% Stock Analytics
DIVIS LABORATORIES ₹239,714.0 Cr -3.8% -3.2% 51.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹174,741.0 Cr -1.7% -7.7% 29.9% Stock Analytics
CIPLA ₹106,061.0 Cr 0.6% -3.8% -11% Stock Analytics
DR REDDYS LABORATORIES ₹101,339.0 Cr 2.9% 4.6% 0.4% Stock Analytics


SMS PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SMS PHARMACEUTICALS

-5.2%

-8.7%

66%

SENSEX

0.2%

-2.8%

-11.2%


You may also like the below Video Courses